Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S100B | P04271 | 1/20 | 0.64 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.56 |
| ▸ | CA12 | O43570 | 1/20 | 0.56 |
| ▸ | CA2 | P00918 | 1/20 | 0.56 |
| ▸ | CA9 | Q16790 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.47 |
| ▸ | GAA | P10253 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | ACHE | P22303 | 2/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3181342 | 1.00 | S100B (0.64) | S100BPTGS2PTGS1CA12CA2 | |
| SCHEMBL2482983 | 1.00 | S100B (0.64) | S100BPTGS2PTGS1CA12CA2 | |
| SCHEMBL2482981 | 1.00 | S100B (0.64) | S100BPTGS2PTGS1CA12CA2 | |
| SCHEMBL10413111 | 0.95 | S100B (0.59) | S100BPTGS2PTGS1CA12CA2 | |
| SCHEMBL10413110 | 0.95 | S100B (0.59) | S100BPTGS2PTGS1CA12CA2 | |
| SCHEMBL4688279 | 0.94 | S100B (0.57) | S100BPTGS2PTGS1CA12CA2 | |
| SCHEMBL4787112 | 0.93 | S100B (0.56) | S100BPTGS2PTGS1CA12CA2 | |
| SCHEMBL4787108 | 0.93 | S100B (0.56) | S100BPTGS2PTGS1CA12CA2 | |
| SCHEMBL10412841 | 0.86 | S100B (0.82) | S100BPTGS2PTGS1CA12CA2 | |
| SCHEMBL10733285 | 0.86 | S100B (0.82) | S100BPTGS2PTGS1CA12CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112679541-B | Preparation method and application of metal organic ternary cyclic compound | 大连理工大学 | 2022-03-18 | — | — | CN | claimed |
| CN-112679541-A | Preparation method and application of metal organic ternary cyclic compound | 大连理工大学 | 2021-04-20 | — | — | CN | claimed |
| CN-112679541-B | Preparation method and application of metal organic ternary cyclic compound | 大连理工大学 | 2022-03-18 | — | — | CN | disclosed |
| US-20210349035-A1 | PATHOGEN MONITORING | PLATYPUS TECHNOLOGIES, LLC | 2021-11-11 | — | — | US | disclosed |
| US-20210318231-A1 | Liquid Crystal-Based Detection of Air Contaminants Using Metal Surfaces | NATIONAL SCIENCE FOUNDATION | 2021-10-14 | — | — | US | disclosed |
| CN-112679541-A | Preparation method and application of metal organic ternary cyclic compound | 大连理工大学 | 2021-04-20 | — | — | CN | disclosed |
| US-10928306-B2 | Functional surfaces for liquid crystal-based detection of chlorine gas | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2021-02-23 | — | — | US | disclosed |
| US-10705262-B2 | Liquid crystal half-wave plate lens | FACEBOOK TECHNOLOGIES, LLC (US) | 2020-07-07 | — | — | US | disclosed |
| US-20190212254-A1 | Functional Surfaces for Liquid Crystal-Based Detection of Chlorine Gas | NATIONAL SCIENCE FOUNDATION | 2019-07-11 | — | — | US | disclosed |
| US-20190212477-A1 | Liquid Crystal Half-Wave Plate Lens | META PLATFORMS TECHNOLOGIES, LLC | 2019-07-11 | — | — | US | disclosed |
| US-10247858-B2 | Liquid crystal half-wave plate lens | FACEBOOK TECHNOLOGIES, LLC (US) | 2019-04-02 | — | — | US | disclosed |
| US-6498156-B2 | TREATING HYPERLIPIDEMIA, ARTERIOSCLEROSIS AND HYPERCHOLESTEROLEMIA | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2002-12-24 | — | — | US | disclosed |
| US-20020137689-A1 | Novel diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2002-09-26 | — | — | US | disclosed |
| US-20020128252-A1 | Diphenylazetidinone derivatives, process for their preparation, medicaments comprising these compounds and their use | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2002-09-12 | — | — | US | disclosed |
| WO-2002050068-A1 | DIPHENYL AZETIDINONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, MEDICAMENTS CONTAINING THESE COMPOUNDS, AND THEIR USE | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2002-06-27 | — | — | WO | disclosed |
| WO-2002050027-A1 | NOVEL 1,2-DIPHENZYLAZETIDINONES, METHOD FOR PRODUCING THE SAME, MEDICAMENTS CONTAINING SAID COMPOUNDS, AND THE USE THEREOF FOR TREATING DISORDERS OF THE LIPID METABOLISM | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2002-06-27 | — | — | WO | disclosed |
| US-4101207-A | Preparation of liquid crystal containing polymeric structure | OWENS-ILLINOIS, INC. (US) | 1978-07-18 | — | — | US | disclosed |
| US-4035060-A | Electro-optic device | DAINIPPON PRINTING CO., LTD (JA) | 1977-07-12 | — | — | US | disclosed |
| US-3944330-A | Electro-optic device | DAINIPPON PRINTING CO., LTD. (JA) | 1976-03-16 | — | — | US | disclosed |
| US-3935337-A | Preparation of liquid crystal containing polymeric structure | OWENS-ILLINOIS, INC. (US) | 1976-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020137689-A1 | Novel diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use | QDPR, NDUFB7, NDUFB6 | S100B 3938/4885PTGS2 1532/4885PTGS1 711/4885 |
| US-20020128252-A1 | Diphenylazetidinone derivatives, process for their preparation, medicaments comprising these compounds and their use | QDPR, NDUFB6, NDUFB7 | S100B 4280/4885PTGS2 1665/4885PTGS1 711/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.